Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST).

Source:http://linkedlifedata.com/resource/pubmed/id/15880334

Download in:

View as

General Info

PMID
15880334